• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON & JOHNSON VISION CARE, INC. - US ACUVUE VITA; LENSES, SOFT CONTACT, DAILY WEAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON & JOHNSON VISION CARE, INC. - US ACUVUE VITA; LENSES, SOFT CONTACT, DAILY WEAR Back to Search Results
Catalog Number ATL
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bacterial Infection (1735); Corneal Scar (1793); Corneal Ulcer (1796); Red Eye(s) (2038); Eye Pain (4467)
Event Date 03/01/2021
Event Type  Injury  
Manufacturer Narrative
Suspect product was discarded.
 
Event Description
On (b)(6) 2021 a patient (pt) called to report a diagnosis of os corneal ulcer while wearing the acuvue® vita¿ brand contact lens (cls).The pt reported the lenses were purchased (b)(6) 2021 and thinks the initial visit to the eye care provider (ecp) was near the end of (b)(6) or beginning of (b)(6) 2021.The pt reported weekly visits with the ecp until the last visit today, (b)(6) 2021.The ecp thought it was a ¿bacterial infection¿ and advised the pt today ((b)(6) 2021) that the corneal ulcer looks healed but has scarring from ¿where the infection was.¿ the location of the os corneal ulcer is unknown.The ecp advised the pt to use rewetting drops and continue with no cls wear.The pt also had an amniotic membrane procedure (date not provided) on the eye.The ecp prescribed besivance q2h while awake for 1 week, then return for a follow-up (fu) appointment.At the fu appointment (date not provided), the pt was instructed to discontinue besivance and use neomycin/polymyxcin b/dexamethasone eye drops q4h until the next fu appointment.At the next fu appointment (date not provided), the pt was instructed to resume besivance q2h while awake.The pt reported using besivance on and off during the entire treatment, 2 or 3 bottles.The pt reports daily cls wear and uses optifree puremoist solution.The pt woke with redness and pain (date was not provided), did not wear the lenses that day, then went to the ecp for evaluation.The suspect os cls was worn for 2 days, then discarded.No additional medical information was provided.Multiple attempts were placed to the pts treating ecp to verify the pt¿s diagnosis and treatment, but nothing additional has been received.A lot history review was performed and revealed the following: the batch record did not show any abnormalities in monomer and solution testing.All parameters tested were within specification.All sterilization requirements were successfully completed.Lot b00x7987 was produced under normal conditions.The suspect os cls was discarded.No additional evaluation can be conducted.If any further relevant information is received, a supplemental report will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACUVUE VITA
Type of Device
LENSES, SOFT CONTACT, DAILY WEAR
Manufacturer (Section D)
JOHNSON & JOHNSON VISION CARE, INC. - US
7500 centurion parkway
jacksonville FL 32256
Manufacturer Contact
rose harrell
7500 centurion parkway
jacksonville, FL 32256
9044433647
MDR Report Key11962325
MDR Text Key263487532
Report Number1057985-2021-00136
Device Sequence Number1
Product Code LPL
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K160212
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 06/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Catalogue NumberATL
Device Lot NumberB00X7987
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 05/18/2021
Initial Date FDA Received06/08/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/28/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age31 YR
-
-